Scientific paper - Original scientific paper
Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration
Diabetes Research and Clinical Practice, 207 (2024); 111056. https://doi.org/10.1016/j.diabres.2023.111056


Cite this document

Gašparini, D., Wensveen, F. M. & Turk Wensveen, T. (2024). Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration. Diabetes Research and Clinical Practice, 207.. doi: 10.1016/j.diabres.2023.111056

Gašparini, Dora, et al. "Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration." Diabetes Research and Clinical Practice, vol. 207, 2024. https://doi.org/10.1016/j.diabres.2023.111056

Gašparini, Dora, Felix M. Wensveen and Tamara Turk Wensveen. "Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration." Diabetes Research and Clinical Practice 207 (2024). https://doi.org/10.1016/j.diabres.2023.111056

Gašparini, D., Wensveen, F. M. and Turk Wensveen, T. (2024) 'Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration', Diabetes Research and Clinical Practice, 207. doi: 10.1016/j.diabres.2023.111056

Gašparini D, Wensveen FM, Turk Wensveen T. Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration. Diabetes Research and Clinical Practice [Internet]. 2024 January [cited 2024 December 02];207. doi: 10.1016/j.diabres.2023.111056

D. Gašparini, F. M. Wensveen and T. Turk Wensveen, "Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration", Diabetes Research and Clinical Practice, vol. 207, January 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:045788. [Accessed: 02 December 2024]

Please login to the repository to save this object to your list.